GLP-1 receptor agonist or SGLT2 inhibitor prescribing became more common for people with type 1 diabetes in recent years, a nationwide cross-sectional analysis found. From 2010 to 2023, the percentage ...
CLEVELAND, Ohio — Patients with Type 1 diabetes have lost the specialized pancreatic cells that produce insulin, putting them ...
Type 1 diabetes has shifted from a condition once associated with early mortality to a chronic disease owing to the development of intensive insulin therapy, continuous glucose monitoring, and hybrid ...
Hosted on MSN
Can We Cure Type 1 Diabetes?
Theres a clich in the type 1 diabetes community that a cure has been five years away for as long as anyone can remember. For decades, patients have been told that researchers were on the verge of a ...
A new consensus report on the management of type 1 diabetes in adults was presented recently at the European Association for the Study of Diabetes (EASD) meetings. This is an EASD/American Diabetes ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results